top of page

Body Fat, Inflammation & Breast Cancer: How Adipose Tissue Becomes an Estrogen Factory


Adipose cells
Adipose cells

When we think about breast cancer risk, we often focus on genetics, screenings, and family history. But one of the most overlooked contributors is something much closer to home: our body fat.


Adipose tissue (body fat) is not just a passive storage site for energy. It’s an active, hormone-producing organ that can influence your risk of developing or recurring breast cancer.


Given that 70% of breast cancers are hormone positive, it's important to talk about how excess fat tissue fuels estrogen production, drives inflammation, and creates an environment where cancer cells thrive—and what you can do to change that story.


Why This Matter


Breast cancer is the most common cancer among Canadian women (excluding non-melanoma skin cancers), and approximately 1 in 8 women will be diagnosed during her lifetime. Additionally, about 65% of Canadian adults have a MI that's in overweight/obese categories. These numbers show that many Canadian women are carrying elevated risk due to weight/adiposity—and so understanding mechanisms is critical for prevention.


Hormonal vs Non-Hormonal Breast Cancers & Body Composition


Breast cancer is not one size fits all. Hormonal (Hormone Receptor–Positive, HR+) cancers have receptors for estrogen (ER+) and/or progesterone (PR+). They are driven by hormone signalling, so excess estrogen, estrogen dominance, and greater aromatase activity can directly feed these cancers.


Non-Hormonal (Hormone Receptor–Negative, HR–, or Triple Negative) cancers lack estrogen or progesterone receptors (or HER2, depending on the subtype). Though they are not driven by estrogen, they can still be affected by body composition through other mechanisms (e.g. inflammation, insulin resistance, adipokines) which influence cancer cell growth, aggressiveness, immune surveillance, and likelihood of recurrence.


So while body fat and estrogen are especially relevant for hormonal cancers (particularly in post-menopausal women), non-hormonal cancers are still impacted by the metabolic and inflammatory changes associated with adiposity.


How Body Composition Differs Before & After Menopause


Before menopause, the ovaries are the main source of estrogen, and the link between body fat and breast cancer is less direct. Some studies even suggest that higher weight may have a weaker or mixed effect in younger women.


After menopause, the picture changes. Once the ovaries stop producing estrogen, fat tissue becomes the main source through a process called aromatization. This makes excess body fat a much stronger risk factor for breast cancer in post-menopausal women, especially for hormone-positive cancers.


Steps for Safe, Sustainable Body Composition Change


You don’t need crash diets or quick fixes. These are steps rooted in science and whole-body support that can really move the prevention needle. Start with one, and gradually stack on others to create a strong internal terrain.


  1. Gradual, Realistic Goals - Aim for slow weight loss (if needed)—even 5-10% reduction over time can meaningfully reduce estrogen, improve insulin sensitivity, and lower inflammation.


  2. Nutrient-Dense, Anti-Inflammatory Eating - Emphasize whole foods: fibrous vegetables, cruciferous vegetables, berries, lean protein, healthy fats (e.g. omega-3s). Reduce refined sugar, processed foods, and trans fats that worsen insulin resistance and inflammation.


  3. Support Estrogen Detoxification - Include cruciferous veggies (broccoli, kale, cauliflower), fiber, enough gut health (healthy microbiome), liver supporting foods, and practices. These help convert and eliminate estrogen and reduce estrogen dominance.


  4. Regular Moderate Exercise + Strength Training - Aim for consistency (30-60 minutes most days). Moderate cardio to burn fat; strength training to preserve lean muscle (which supports metabolic rate). Exercise also improves insulin sensitivity.


  5. Optimize Sleep & Manage Stress - Poor sleep and stress raise cortisol, which can worsen insulin resistance, increase fat storage (especially abdominal), and disrupt hormonal balance.


  6. Monitor Key Biomarkers - Working with a practitioner, check fasting insulin, HbA1c, lipid panel, hormone levels (estrogen / progesterone in HR+ risk cases), inflammatory markers (e.g. CRP), thyroid function. For many women, correcting hypothyroidism (if present) also helps with metabolism and weight regulation.


  7. Lifestyle & Environmental Adjustments - Reduce exposure to endocrine-disrupting chemicals, limit unnecessary medical radiation, maintain a healthy weight through diet and activity rather than restrictive or extreme programs.


Moving From Awareness to Prevention


During Breast Cancer Awareness Month, we see beautiful campaigns, walks, and ribbons. And while those efforts raise funds and save lives by supporting treatments, awareness alone is only one part. Prevention care—addressing body composition, estrogen balance, insulin resistance, inflammation—is the best care because it helps reduce risk before disease shows up.


If you are concerned about breast cancer risk, especially hormone receptor-positive types, body composition change isn’t just about aesthetics—it’s about changing the hormonal and metabolic environment in which cancer thrives.


If you’d like help assessing your own risk profile and creating a holistic plan that works for your body, I offer free discovery calls. Book yours here.


References


  • Canadian Cancer Society. (2024). Breast cancer statistics. Retrieved from https://cancer.ca

  • World Cancer Research Fund / American Institute for Cancer Research (WCRF/AICR). (2018). Diet, Nutrition, Physical Activity and Breast Cancer.

  • Friedenreich, C.M., Neilson, H.K., & Lynch, B.M. (2010). State of the epidemiological evidence on physical activity and cancer prevention. European Journal of Cancer, 46(14), 2593–2604.

  • Renehan, A.G., Tyson, M., Egger, M., Heller, R.F., & Zwahlen, M. (2008). Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The Lancet, 371(9612), 569–578.

  • Goodwin, P.J., & Stambolic, V. (2015). Impact of the obesity epidemic on cancer progression and survival. Current Oncology, 22(Suppl 2), S33–S41.

  • Statistics Canada. (2023). Overweight and obesity in Canada: A health concern. Retrieved from https://www.statcan.gc.ca

Comments


bottom of page